Biomarin Pharmaceutical Inc Cash Flow Reinvestment Rate
Biomarin Pharmaceutical Inc cash flow reinvestment rate. Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Reinvestment Rate of 0.17x as of June 2026, reinvesting $28.82 Million (capex $28.82 Million ) from operating cash flow of $168.11 Million. Explore Biomarin Pharmaceutical Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Biomarin Pharmaceutical Inc (2009–2025)
Cash flow reinvestment rate of Biomarin Pharmaceutical Inc from 2009 to 2025. Historical reinvestment intensity for Biomarin Pharmaceutical Inc across 12 annual periods. Explore BMRN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Biomarin Pharmaceutical Inc Cash Flow Reinvestment Rate by Year (2009–2025)
Biomarin Pharmaceutical Inc cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Biomarin Pharmaceutical Inc. For the full cash flow conversion analysis, see BMRN operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | $121.11 Million | $827.99 Million | $103.04 Million | ▼ -64.2% |
| 2024 | 0.41x | $233.91 Million | $572.84 Million | $97.42 Million | ▼ -68.8% |
| 2023 | 1.31x | $208.60 Million | $159.26 Million | $107.61 Million | ▲ +63.4% |
| 2022 | 0.80x | $140.99 Million | $175.90 Million | $120.96 Million | ▼ -49.7% |
| 2021 | 1.59x | $485.54 Million | $304.54 Million | $119.22 Million | ▼ -16.9% |
| 2020 | 1.92x | $163.69 Million | $85.36 Million | $137.52 Million | ▼ -63.5% |
| 2019 | 5.25x | $253.21 Million | $48.26 Million | $145.03 Million | ▼ -78.9% |
| 2018 | 24.92x | $503.60 Million | $20.21 Million | $144.62 Million | ▲ +124.3% |
| 2012 | 11.11x | $195.65 Million | $17.61 Million | $44.57 Million | ▼ -4.8% |
| 2011 | 11.67x | $218.88 Million | $18.75 Million | $154.22 Million | ▲ +219.9% |
| 2010 | 3.65x | $68.39 Million | $18.75 Million | $49.46 Million | ▲ +256.4% |
| 2009 | 1.02x | $89.80 Million | $87.73 Million | $89.80 Million | — |